Heron Therapeutics, Inc. · NASDAQ:HRTX

Forbes William P exercised options for 23,464 Heron Therapeutics, Inc. shares (Form 4)

Traded Apr 30, 2026 · Filed May 4, 2026

On Apr 30, 2026, Forbes William P (EVP, Chief Development Officer) exercised options for 23,464 Heron Therapeutics, Inc. shares, leaving 209,111 shares. Filed May 4, 2026 (Form 4).

Options exercised
23,464 shares
Holding after
209,111 shares
Trading plan
No
Role
EVP, Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockOption exercise11,694197,341Direct
Apr 30, 2026Common StockOption exercise11,770209,111Direct

Source

View original at SEC

Related